Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 24, 2018

Primary Completion Date

March 25, 2021

Study Completion Date

January 28, 2024

Conditions
Heart FailureCardiomyopathy, Dilated
Interventions
DEVICE

AccuCinch® Ventricular Restoration System

AccuCinch® Ventricular Restoration System in Patients with Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation

Trial Locations (19)

10029

Mount Sinai, New York

17033

Penn State Health Milton S. Hershey Medical Center, Hershey

17101

PinnacleHealth Cardiovascular Institute, Harrisburg

22908

University of Virginia School of Medicine, Charlottesville

24014

Virginia Tech Carilion School of Medicine and Research Institute, Roanoke

30309

Piedmont Heart, Atlanta

30322

Emory University, Atlanta

40202

University of Louisville, Louisville

44106

University Hospitals Cleveland Medical Center, Cleveland

45219

The Christ Hospital, Cincinnati

55407

Minneapolis Heart Foundation Institute, Minneapolis

70360

Cardiovascular Institute of the South, Houma

73120

Oklahoma Heart Hospital, Oklahoma City

77020

Baylor College of Medicine St. Luke's Medical Center, Houston

78756

Austin Heart, Austin

84109

Intermountain Medical Center, Salt Lake City

94143

University of California, San Francisco, San Francisco

98195

University of Washington Medicine, Seattle

07601

Hackensack University Medical Center, Hackensack

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Ancora Heart, Inc.

INDUSTRY

NCT03560167 - Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation | Biotech Hunter | Biotech Hunter